Article ID Journal Published Year Pages File Type
8453157 Journal of Bone Oncology 2018 5 Pages PDF
Abstract
The association of variants of FASL and ABCC5 with survival outcome after chemotherapy was validated in patients with osteosarcoma. Our findings may provide a new insight into a more personalized treatment for patients with osteosarcoma.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Variants of FasL and ABCC5 are predictive of outcome after chemotherapy-based treatment in osteosarcoma
Authors
, , , , , ,